MANNKIND CORP Income Statement
MNKD / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 15 fiscal years. All figures from audited SEC 10-K filings.
MANNKIND CORP reported $349M in revenue and $6M in net income for FY2025. Revenue has grown at a 88.2% compound annual rate over the past 14 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -2.74 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $349.0M | $285.5M | $199.0M | $99.8M | $75.4M | $65.1M | $63.0M | $27.9M | $11.7M | $174.8M | $0 | $0 | $0 | $35.0K | $50.0K |
| Cost of Revenue | $26.8M | $17.4M | $20.9M | $16.0M | $16.8M | $15.1M | $20.1M | $19.4M | $17.2M | $17.1M | $64.7M | - | - | - | - |
| SG&A Expense | $144.1M | $94.3M | $94.3M | $91.5M | $77.4M | $59.0M | $74.7M | $79.7M | $75.0M | $46.9M | $41.0M | $79.4M | $59.7M | $45.5M | $40.6M |
| R&D Expense | $66.3M | $45.9M | $31.3M | $19.7M | $12.3M | $6.2M | $6.9M | $8.7M | $14.1M | $14.9M | $29.7M | $100.2M | $109.7M | $101.5M | $100.0M |
| Operating Income | $38.8M | $72.6M | $8.7M | -$64.1M | -$47.0M | -$47.9M | -$44.6M | -$76.6M | -$108.2M | $67.3M | -$344.7M | -$179.6M | -$169.4M | -$147.0M | -$140.5M |
| Interest Expense | - | - | $15.2M | $15.0M | $15.2M | $9.5M | $6.3M | $5.1M | $9.5M | $15.6M | $24.1M | $20.4M | $21.5M | $21.6M | $21.8M |
| Income Tax | -$4.5M | $2.9M | $1.6M | $0 | $0 | -$218.0K | $0 | $240.0K | $51.0K | $0 | $0 | $0 | $0 | -$408.0K | $26.0K |
| Net Income | $5.9M | $27.6M | -$11.9M | -$87.4M | -$80.9M | -$57.2M | -$51.9M | -$87.0M | -$117.3M | $125.7M | -$368.4M | -$198.4M | -$191.5M | -$169.4M | -$160.8M |
| EPS (Basic) | -$0.04 | -$0.34 | -$0.32 | -$0.26 | - | - | - | $1.37 | -$4.54 | -$2.57 | - | - | - | - | - |
| EPS (Diluted) | -$0.04 | -$0.34 | -$0.32 | -$0.26 | -$0.26 | -$0.27 | -$0.60 | $1.36 | -$4.54 | -$2.57 | -$0.64 | -$0.94 | -$1.32 | -$1.50 | -$2.07 |
| Shares Outstanding | 303.0M | 270.0M | 263.8M | 251.5M | 242.1M | 211.8M | 187.0M | 119.1M | 95.7M | 85.7M | 406.1M | 369.4M | 31.3M | 131.5M | 127.8M |
| Operating Margin | 11.1% | 25.4% | 4.4% | -64.3% | -62.3% | -73.6% | -70.8% | -274.9% | -921.1% | 38.5% | - | - | - | -419885.7% | -281078.0% |
| Profit Margin | 1.7% | 9.7% | -6.0% | -87.6% | -107.3% | -87.9% | -82.3% | -312.2% | -999.0% | 71.9% | - | - | - | -483902.9% | -321608.0% |